The Study
Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial.
This study is like a fair test where people were randomly given either the medicine (exenatide) or a fake pill (placebo). Because it was random and fair, we can say the medicine likely caused the differences we saw, like fewer deaths and fewer repeat heart failure hospital stays. But for some groups, like people who already had heart failure, the results are more like clues, not proof.
Analysis score
Maximum 90 for a randomized controlled trial.
Where the score came from
A special weekly shot for diabetes called exenatide helps some people live longer and avoid repeat heart failure hospital stays—but only if they don’t already have heart failure.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 590 / 100
Quality score
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Key takeaways
Summary
Based on the study abstract and findings.
- 1This means the shot helps people with diabetes stay healthier and out of the hospital more often, especially if their heart is still strong.
- 2People without heart failure who took exenatide were 21% less likely to die.
- 3The shot cut repeat heart failure hospital visits by 18%.
- 4But it didn’t stop the first hospital stay for heart failure.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Circulation
Year
2019
Authors
M. Fudim, Jennifer A. White, N. Pagidipati, Y. Lokhnygina, J. Wainstein, J. Murín, N. Iqbal, P. Öhman, R. Lopes, B. Reicher, R. Holman, Adrian F. Hernandez, R. Mentz
Related Content
Claims (6)
Taking a weekly diabetes shot called exenatide may help lower the chance of dying or ending up in the hospital with heart failure for people with type 2 diabetes.
If you have type 2 diabetes and already have heart failure, the weekly diabetes shot exenatide might not help you live longer or keep you out of the hospital for heart problems. But if your heart is healthy, it could lower your risk of dying by 21%.
A weekly diabetes shot called exenatide doesn’t lower the chance of ending up in the hospital for heart failure for the first time in people with type 2 diabetes — it’s basically neutral, even though it might help if someone already has heart issues.
A weekly diabetes shot called exenatide may help people with type 2 diabetes live longer, especially if they don’t already have heart failure.
Taking a weekly diabetes shot called exenatide doesn’t stop the first heart failure hospital stay, but it does cut down on how often people end up back in the hospital for heart problems by about 18%.
A diabetes drug made from Gila monster spit doesn't just help blood sugar — it can also help people lose weight, protect the heart, and even reduce cravings for things like alcohol or drugs.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.